These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

639 related items for PubMed ID: 15249365

  • 1. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
    Renno RZ, Terada Y, Haddadin MJ, Michaud NA, Gragoudas ES, Miller JW.
    Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365
    [Abstract] [Full Text] [Related]

  • 2. Verteporfin photodynamic therapy in the rat model of choroidal neovascularization: angiographic and histologic characterization.
    Zacks DN, Ezra E, Terada Y, Michaud N, Connolly E, Gragoudas ES, Miller JW.
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2384-91. PubMed ID: 12091441
    [Abstract] [Full Text] [Related]

  • 3. Factor VII-verteporfin for targeted photodynamic therapy in a rat model of choroidal neovascularization.
    Lu F, Hu Z, Sinard J, Garen A, Adelman RA.
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3890-6. PubMed ID: 19357351
    [Abstract] [Full Text] [Related]

  • 4. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.
    Husain D, Kramer M, Kenny AG, Michaud N, Flotte TJ, Gragoudas ES, Miller JW.
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2322-31. PubMed ID: 10476799
    [Abstract] [Full Text] [Related]

  • 5. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy. Selective treatment of choroidal neovascularization in monkeys.
    Kramer M, Miller JW, Michaud N, Moulton RS, Hasan T, Flotte TJ, Gragoudas ES.
    Ophthalmology; 1996 Mar; 103(3):427-38. PubMed ID: 8600419
    [Abstract] [Full Text] [Related]

  • 6. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.
    Schmidt-Erfurth U, Miller JW, Sickenberg M, Laqua H, Barbazetto I, Gragoudas ES, Zografos L, Piguet B, Pournaras CJ, Donati G, Lane AM, Birngruber R, van den Berg H, Strong HA, Manjuris U, Gray T, Fsadni M, Bressler NM.
    Arch Ophthalmol; 1999 Sep; 117(9):1177-87. PubMed ID: 10496389
    [Abstract] [Full Text] [Related]

  • 7. Choroidal neovascularization reduced by targeted drug delivery with cationic liposome-encapsulated paclitaxel or targeted photodynamic therapy with verteporfin encapsulated in cationic liposomes.
    Gross N, Ranjbar M, Evers C, Hua J, Martin G, Schulze B, Michaelis U, Hansen LL, Agostini HT.
    Mol Vis; 2013 Sep; 19():54-61. PubMed ID: 23335851
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes.
    Berdugo M, Bejjani RA, Valamanesh F, Savoldelli M, Jeanny JC, Blanc D, Ficheux H, Scherz A, Salomon Y, BenEzra D, Behar-Cohen F.
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1633-44. PubMed ID: 18385085
    [Abstract] [Full Text] [Related]

  • 9. Photodynamic therapy of experimental choroidal neovascularization in the mouse.
    Odergren A, Ming Y, Kvanta A.
    Curr Eye Res; 2006 Sep; 31(9):765-74. PubMed ID: 16966149
    [Abstract] [Full Text] [Related]

  • 10. Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey.
    Husain D, Kim I, Gauthier D, Lane AM, Tsilimbaris MK, Ezra E, Connolly EJ, Michaud N, Gragoudas ES, O'Neill CA, Beyer JC, Miller JW.
    Arch Ophthalmol; 2005 Apr; 123(4):509-16. PubMed ID: 15824225
    [Abstract] [Full Text] [Related]

  • 11. Zinc phthalocyanine tetrasulfonate (ZnPcS4): a new photosensitizer for photodynamic therapy in choroidal neovascularization.
    Huang Y, Xu G, Peng Y, Lin H, Zheng X, Xie M.
    J Ocul Pharmacol Ther; 2007 Aug; 23(4):377-86. PubMed ID: 17803437
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin.
    Schmidt-Erfurth UM, Michels S.
    Ophthalmology; 2003 Jul; 110(7):1306-14. PubMed ID: 12867383
    [Abstract] [Full Text] [Related]

  • 14. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [Abstract] [Full Text] [Related]

  • 15. Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: mono-L-aspartyl chlorin e6.
    Mori K, Yoneya S, Anzail K, Kabasawa S, Sodeyama T, Peyman GA, Moshfeghi DM.
    Retina; 2001 Oct; 21(5):499-508. PubMed ID: 11642380
    [Abstract] [Full Text] [Related]

  • 16. Photoreceptor protection after photodynamic therapy using dexamethasone in a rat model of choroidal neovascularization.
    She H, Nakazawa T, Matsubara A, Connolly E, Hisatomi T, Noda K, Kim I, Gragoudas ES, Miller JW.
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):5008-14. PubMed ID: 18421085
    [Abstract] [Full Text] [Related]

  • 17. Sequence of early vascular events after photodynamic therapy.
    Michels S, Schmidt-Erfurth U.
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):2147-54. PubMed ID: 12714655
    [Abstract] [Full Text] [Related]

  • 18. [Novel approach for management of age-related macular degeneration--antiangiogenic therapy and retinal regenerative therapy].
    Tamaki Y.
    Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):232-68; discussion 269. PubMed ID: 17402564
    [Abstract] [Full Text] [Related]

  • 19. N-acetylcysteine protects against chorioretinal damage induced by photodynamic therapy for experimental choroidal neovascularization in a rat model.
    Kim TW, Moon JW, Yu HG.
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():12-17. PubMed ID: 29679669
    [Abstract] [Full Text] [Related]

  • 20. Photodynamic therapy with verteporfin for choroidal neovascularization in patients with diabetic retinopathy.
    Ladd BS, Solomon SD, Bressler NM, Bressler SB.
    Am J Ophthalmol; 2001 Nov; 132(5):659-67. PubMed ID: 11704027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.